A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder.

PubWeight™: 2.55‹?› | Rank: Top 2%

🔗 View Article (PMID 19879039)

Published in Eur Urol on October 23, 2009

Authors

Beat Roth1, Michael P Wissmeyer, Pascal Zehnder, Frédéric D Birkhäuser, George N Thalmann, Thomas M Krause, Urs E Studer

Author Affiliations

1: Department of Urology, University of Bern, 3010 Bern, Switzerland.

Articles citing this

Lymph node-positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity. Eur Urol (2012) 1.01

Standard cystectomy fits all: truth or myth? Transl Androl Urol (2015) 0.87

Extent of pelvic lymph node dissection during radical cystectomy: where and why! Eur Urol (2009) 0.82

Optimization of sentinel lymph node mapping in bladder cancer using near-infrared fluorescence imaging. J Surg Oncol (2014) 0.82

Open radical cystectomy: still the gold standard for muscle invasive bladder cancer. World J Urol (2015) 0.82

Laparoscopic sentinel lymph node biopsy for prostate cancer: the relevance of locations outside the extended dissection area. Prostate Cancer (2011) 0.81

Comparison of the clinical effectiveness of 3D and 2D imaging systems for laparoscopic radical cystectomy with pelvic lymph node dissection. J Int Med Res (2016) 0.79

Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation. World J Urol (2013) 0.79

Lymphadenectomy in management of invasive bladder cancer. Int J Surg Oncol (2011) 0.78

Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract. World J Clin Oncol (2015) 0.78

Role of lymph node dissection in management of bladder cancer. Int J Clin Oncol (2011) 0.77

Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy? World J Urol (2012) 0.75

Pelvic Lymph Node Dissection may be Limited on the Contralateral Side in Strictly Unilateral Bladder Cancer without Compromising Oncological Radicality. Bladder Cancer (2016) 0.75

Reply from Authors to the Editorial Comment. Bladder Cancer (2016) 0.75

Re: a new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. J Urol (2011) 0.75

Extent of pelvic lymph node dissection during radical cystectomy: is bigger better? Rev Urol (2014) 0.75

Beyond penile cancer, is there a role for sentinel node biopsy in urological malignancies? Clin Transl Imaging (2016) 0.75

Pelvic lymph node dissection in the context of radical cystectomy: a thorough insight into the connection between patient, surgeon, pathologist and treating institution. Res Rep Urol (2013) 0.75

[Urothelial carcinoma]. Urologe A (2011) 0.75

Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta. World J Urol (2015) 0.75

Differences in histopathological evaluation of standard lymph node dissections result in differences in nodal count but not in survival. World J Urol (2012) 0.75

Articles by these authors

Readaptation of the peritoneum following extended pelvic lymphadenectomy and cystectomy has a significant beneficial impact on early postoperative recovery and complications: results of a prospective randomized trial. Eur Urol (2010) 4.18

Pelvic lymph node dissection in prostate cancer. Eur Urol (2009) 3.93

Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol (2003) 3.58

Antegrade perfusion with bacillus Calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit? Eur Urol (2011) 3.47

Long-term renal function after urinary diversion by ileal conduit or orthotopic ileal bladder substitution. Eur Urol (2011) 3.44

The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study. Eur Urol (2007) 3.20

Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol (2008) 2.83

Twenty years experience with an ileal orthotopic low pressure bladder substitute--lessons to be learned. J Urol (2006) 2.82

Contemporary role of androgen deprivation therapy for prostate cancer. Eur Urol (2011) 2.68

Face, content and construct validity of a novel robotic surgery simulator. J Urol (2011) 2.66

Urinary diversion. Urology (2007) 2.65

Nerve sparing open radical retropubic prostatectomy--does it have an impact on urinary continence? J Urol (2006) 2.65

Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer. Sci Transl Med (2012) 2.64

Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy. Eur Urol (2008) 2.46

High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. Cancer Res (2010) 2.39

Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy. J Clin Oncol (2003) 2.33

Is pelvic lymph node dissection necessary in patients with a serum PSA<10ng/ml undergoing radical prostatectomy for prostate cancer? Eur Urol (2006) 2.32

Restrictive deferred hydration combined with preemptive norepinephrine infusion during radical cystectomy reduces postoperative complications and hospitalization time: a randomized clinical trial. Anesthesiology (2014) 2.25

Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer. Eur J Cancer (2012) 2.15

Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol (2011) 2.14

Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial. Lancet Oncol (2012) 2.06

Occlusion of seminal vesicles increases sexual activity in a mouse model. Eur Urol (2012) 2.03

Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. Eur Urol (2009) 1.99

A prospective randomized trial comparing 2 lithotriptors for stone disintegration and induced renal trauma. J Urol (2003) 1.84

Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging. Radiology (2014) 1.78

Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer. Eur Urol (2013) 1.77

Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution? Eur Urol (2010) 1.76

Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease. Am J Pathol (2002) 1.71

Long-term results of standard procedures in urology: the ileal neobladder. World J Urol (2006) 1.68

Extracorporeal shock wave lithotripsy of lower calyx calculi: how much is treatment outcome influenced by the anatomy of the collecting system? Eur Urol (2007) 1.68

Is newer always better? A comparative study of 3 lithotriptor generations. J Urol (2005) 1.67

Ultrasound assessment of detrusor thickness in men-can it predict bladder outlet obstruction and replace pressure flow study? J Urol (2006) 1.65

Individualized seminal vesicle sparing cystoprostatectomy combined with ileal orthotopic bladder substitution achieves good functional results. J Urol (2010) 1.64

Smoking negatively impacts renal cell carcinoma overall and cancer-specific survival. Cancer (2011) 1.64

Detection rate and operating time required for gamma probe-guided sentinel lymph node resection after injection of technetium-99m nanocolloid into the prostate with and without preoperative imaging. Eur Urol (2007) 1.64

Prognostic value of microvascular invasion in predicting the cancer specific survival and risk of metastatic disease in renal cell carcinoma: a multicenter investigation. J Urol (2011) 1.63

A prospective randomised trial comparing the modified HM3 with the MODULITH® SLX-F2 lithotripter. Eur Urol (2011) 1.61

Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladder. Am J Surg Pathol (2005) 1.61

The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer. Eur Urol (2010) 1.61

Is there an indication for frozen section examination of the ureteral margins during cystectomy for transitional cell carcinoma of the bladder? J Urol (2006) 1.59

BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo. Am J Pathol (2007) 1.58

Renal oxygenation changes during acute unilateral ureteral obstruction: assessment with blood oxygen level-dependent mr imaging--initial experience. Radiology (2008) 1.58

Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy? J Urol (2004) 1.56

Increased proximal urethral sensory threshold after radical pelvic surgery in women. Neurourol Urodyn (2007) 1.53

Parenteral nutrition does not improve postoperative recovery from radical cystectomy: results of a prospective randomised trial. Eur Urol (2012) 1.52

Long-term voiding pattern of patients with ileal orthotopic bladder substitutes. J Urol (2002) 1.50

Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol (2002) 1.50

Long-term outcome of ileal conduit diversion. J Urol (2003) 1.50

The efficiency of excretory urography to detect upper urinary tract tumors after cystectomy for urothelial cancer. J Urol (2007) 1.49

The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol (2009) 1.49

Extracapsular extension but not the tumour burden of lymph node metastases is an independent adverse risk factor in lymph node-positive bladder cancer. Histopathology (2011) 1.46

Benign prostatic obstruction and parkinson's disease--should transurethral resection of the prostate be avoided? J Urol (2009) 1.45

Is bilateral extended pelvic lymphadenectomy necessary for strictly unilateral invasive bladder cancer? J Urol (2012) 1.45

Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management. Adv Anat Pathol (2011) 1.45

Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy. BJU Int (2014) 1.44

Percutaneous radiofrequency ablation of virtual tumours in canine kidney using Global Positioning System-like technology. BJU Int (2011) 1.43

ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary diversion. Eur Urol (2012) 1.42

Is eligibility for a chemotherapy protocol a good prognostic factor for invasive bladder cancer after radical cystectomy? J Clin Oncol (2004) 1.40

Effect of thalamic deep brain stimulation on lower urinary tract function. Eur Urol (2007) 1.40

Refractory chronic pelvic pain syndrome in men: can transcutaneous electrical nerve stimulation help? BJU Int (2013) 1.40

Diabetes mellitus: does it impair urinary continence after radical cystoprostatectomy and ileal orthotopic bladder substitution? Eur Urol (2007) 1.39

Robot-assisted cystectomy: does it meet expectations? Eur Urol (2010) 1.37

Irrigation of continent catheterizable ileal pouches: tap water can replace sterile solutions because it is safe, easy, and economical. Eur Urol (2011) 1.37

Interference with the microenvironmental support impairs the de novo formation of bone metastases in vivo. Cancer Res (2005) 1.33

In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue. Prostate (2009) 1.33

Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours. Eur Urol (2011) 1.24